Evidence map›Paper›PMID 35846501›Full record

ArticleThe Malaysian journal of medical sciences : MJMS2022

The Translation Process of Pharmaceutical Care Network Europe v9.00 to Bahasa Indonesia: An Instrument to Detect Drug-Related Problem.

Muhammad Aldila Satria, Retnosari Andrajati, Sudibyo Supardi

Abstract read
In one paragraph

Article in The Malaysian journal of medical sciences : MJMS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muhammad Aldila SatriaFaculty of Pharmacy, Universitas Indonesia, Depok, West Java, Indonesia.
Retnosari AndrajatiFaculty of Pharmacy, Universitas Indonesia, Depok, West Java, Indonesia.
Sudibyo SupardiNational Institute of Health Research and Development, Indonesian Ministry of Health, Jakarta, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Drug-related problems (DRPs) remain a major health challenge in tertiary health services such as hospitals in Indonesia. These problems are detected and solved using classification systems such as Pharmaceutical Care Network Europe (PCNE). Therefore, this study aims to obtain a valid and reliable Bahasa Indonesia version of the PCNE. Methods: A draft of the Bahasa Indonesia version of the PCNE v9.00 was discussed by four experts from May to August 2020 using the Delphi method. Furthermore, the instrument was assessed for its readability, clarity and comprehensiveness by 46 hospital pharmacists throughout Indonesia. In October 2020, two pharmacists from Haji General Hospital, Makassar, Indonesia carried out the inter-rater agreement to assess 20 cases where the proportion of coding matches between both raters were observed. Results: The instrument was found to be valid after passing the face and content validity, and the Scale Content Validity Index (S-CVI) value for each PCNE domain was 0.91, 0.89, 0.93, 0.97 and 0.93, respectively. Moreover, there was a fair agreement between the two raters that ranged between 40%-90%. Also, kappa statistics showed a substantial agreement on the 'Problems' and 'Causes' domains. Conclusion: The Bahasa Indonesia version of the PCNE v9.00 instrument passed face and content validity as well as inter-agreement to be used in hospital settings.

Indexed as

drug-related problemPharmaceutical Care Network Europereliabilitytranslationvalidity

Identifiers

PMID35846501
PMCPMC9249413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.